• IonQ partnered with QC Ware to demonstrate a hybrid quantum-classical drug-discovery workflow using IonQ Forte via Amazon Braket.
• Test modeled the cytochrome P450nor heme active site, calculating electrostatic interaction energy within 0.5 kcal/mol, about 4%, of benchmarks.
• Result met the 1 kcal/mol chemical-accuracy threshold, supporting earlier candidate ranking and metabolic-risk screening in biopharma research.
• Workflow used Promethium GPU preprocessing to map a 115-atom system to an 8-qubit active space measured on Forte.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IONQ Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA37996) on September 01, 2026, and is solely responsible for the information contained therein.